Furey John has filed 4 insider transactions across 2 companies since July 2024.
Most recent transaction: a grant/award of 3041 shares of Vaxcyte, Inc. ($PCVX) on June 12, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Vaxcyte, Inc. | $PCVX | Furey John | Director | A | Common Stock | 3041 | $0.00 | 3,041.0000 | 121,997,348 | 9999.99% | 0.00% |
| June 12, 2025 | Vaxcyte, Inc. | $PCVX | Furey John | Director | A | Stock Option (right to buy) | 15372 | $0.00 | 15,372.0000 | 121,997,348 | 9999.99% | 0.01% |
| July 2, 2024 | Vaxcyte, Inc. | $PCVX | Furey John | Director | A | Stock Option (right to buy) | 16760 | $0.00 | 16,760.0000 | 97,157,690 | 9999.99% | 0.02% |
| July 1, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Furey John | Director | A | Option to purchase Ordinary Shares | 660000 | $0.00 | 660,000.0000 | 1,559,183,774 | 9999.99% | 0.04% |